Life Science Institute, Inc.   Report issue

For profit Phase 1
Founded: Tokyo Japan (2014)

Organization Overview

First Clinical Trial
2020
NCT04261335
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Life Science Institute, Inc.